January 9, 2024 – Start Medical Product Development

Free Design Audit Available - Click Here for Details

Blog

- January 9, 2024

Neurolief’s Relivion® Secures Regulatory Approval in Japan, Pioneering At-Home Migraine Treatment

January 9, 2024

Neurolief announces the approval of its neuromodulation device, Relivion®, by the Japanese Ministry of Health, Labor and Welfare (MHLW).

Biosense Webster wins Japanese approval for Varipulse pulsed field ablation

January 9, 2024

Johnson & Johnson MedTech’s Biosense Webster today announced Japanese approval for its Varipulse platform for treating AFib.

Team develops app to help train the brain to overcome tinnitus

January 9, 2024

An international research team has shown that the debilitating impact of tinnitus can be effectively reduced in just weeks by a training course and sound therapy delivered via a smartphone app